Skip to main content
Caplight Logo









Coologics

Coologics

Private
Broadview Heights, OhioHealthcare & Life Scienceshttps://vlisse.com

Last Round

Seed

Sep 1, 2026

Total Funding Raised

$3M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Coologics operates in Healthcare & Life Sciences and is based in Broadview Heights, Ohio. Its latest recorded funding round was a Seed round in April 2025.

Coologics is a therapeutic devices company that has developed Vlisse, a patented, drug-free medical device that treats vaginal infections.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Patient Engagement

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Coologics Comparables

Compare Coologics with similar companies based on industry and business-model similarity.

Coologics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Cern Corporation
90%
Zero Candida Technologies Inc.
79%
UVISA Health
77%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Coologics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedSep 1, 2026
SeedApr 23, 2025
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Coologics Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 1, 2026

    $1M raised in Seed Round.

  • Apr 23, 2025

    $3M round led by Prevail Venture Capital and Dream Ventures

Book a demo to see all signals

For institutional investors. Book with your work email.

Coologics Filings

Explore SEC and related filing metadata, where available.

Coologics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Coologics's valuation, stock price, and market status.

Is Coologics a public or private company?

Coologics is a private company.

What is the current stock price of Coologics?

Coologics is a private company, so its shares have no public market price. Caplight tracks Coologics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Coologics worth (valuation)?

Valuation information for Coologics is not publicly available.

Can I buy Coologics stock?

Coologics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Coologics's last funding round?

Coologics's most recent funding round was Seed on September 1, 2026.

Who are the main investors in Coologics?

Key investors in Coologics include Dream Ventures, Prevail Venture Capital.

Will Coologics IPO soon?

No public IPO plans have been announced for Coologics.

How can I track Coologics secondary market activity?

Caplight tracks bids, offers, and trades in Coologics's shares on secondary markets.

Firmographic Details

HeadquartersBroadview Heights, Ohio
Year Founded2019
Last FundingSep 1, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?